Loading...

Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

BACKGROUND: The aim of this study was to determine the maximum tolerated dose (MTD), dose limiting toxicities (DLTs), and determine the phase II dose for the combination of irinotecan-carboplatin-paclitaxel given as induction chemotherapy and with concomitant chest radiotherapy for patients with Sta...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Choong, Nicholas W., Vokes, Everett E., Haraf, Daniel J., Tothy, Peter K., Ferguson, Mark K., Kasza, Kristen, Rudin, Charles M., Hoffman, Philip C., Krauss, Stuart A., Szeto, Livia, Mauer, Ann M.
Format: Artigo
Sprog:Inglês
Udgivet: 2008
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742080/
https://ncbi.nlm.nih.gov/pubmed/18166842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31815e8566
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!